Evidence map›Paper›PMID 38749423›Full record

ArticleCell2024

An age-progressive platelet differentiation path from hematopoietic stem cells causes exacerbated thrombosis.

Donna M Poscablo, Atesh K Worthington, Stephanie Smith-Berdan, Marcel G E Rommel, Bryce A Manso, Reheman Adili, Lydia Mok, Roman E Reggiardo, Taylor Cool, Raana Mogharrab and 8 more

Abstract read
In one paragraph

Article in Cell, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Hematopoietic Aging and Leukemia: Mechanistic and Therapeutic Insights.International journal of molecular sciences · 2026
    Review
  11. Article
  12. Article
  13. Article
  14. Research progress on blood therapy for anti-aging.Journal of advanced research · 2026
    Review
  15. Article
  16. Review
  17. Dysregulated Bone Marrow Contributes to Glomerular Injury through Soluble Factors.Journal of the American Society of Nephrology : JASN · 2026
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors.

Donna M PoscabloInstitute for the Biology of Stem Cells, University of California, Santa Cruz, Santa Cruz, CA 95064, USA; Program in Biomedical Science and Engineering, University of California, Santa Cruz, Santa Cruz, CA 95064, USA.
Atesh K WorthingtonInstitute for the Biology of Stem Cells, University of California, Santa Cruz, Santa Cruz, CA 95064, USA; Program in Biomedical Science and Engineering, University of California, Santa Cruz, Santa Cruz, CA 95064, USA.
Stephanie Smith-BerdanInstitute for the Biology of Stem Cells, University of California, Santa Cruz, Santa Cruz, CA 95064, USA; Biomolecular Engineering, University of California, Santa Cruz, Santa Cruz, CA 95064, USA.
Marcel G E RommelInstitute for the Biology of Stem Cells, University of California, Santa Cruz, Santa Cruz, CA 95064, USA.
Bryce A MansoInstitute for the Biology of Stem Cells, University of California, Santa Cruz, Santa Cruz, CA 95064, USA.
Reheman AdiliDepartment of Pharmacology, University of Michigan, Ann Arbor, MI 48109, USA.
Lydia MokProgram in Biomedical Science and Engineering, University of California, Santa Cruz, Santa Cruz, CA 95064, USA.
Roman E ReggiardoInstitute for the Biology of Stem Cells, University of California, Santa Cruz, Santa Cruz, CA 95064, USA; Program in Biomedical Science and Engineering, University of California, Santa Cruz, Santa Cruz, CA 95064, USA.
Taylor CoolInstitute for the Biology of Stem Cells, University of California, Santa Cruz, Santa Cruz, CA 95064, USA; Program in Biomedical Science and Engineering, University of California, Santa Cruz, Santa Cruz, CA 95064, USA.
Raana MogharrabInstitute for the Biology of Stem Cells, University of California, Santa Cruz, Santa Cruz, CA 95064, USA; Program in Biomedical Science and Engineering, University of California, Santa Cruz, Santa Cruz, CA 95064, USA.
Jenna MyersInstitute for the Biology of Stem Cells, University of California, Santa Cruz, Santa Cruz, CA 95064, USA; Program in Biomedical Science and Engineering, University of California, Santa Cruz, Santa Cruz, CA 95064, USA.
Steven DahmenInstitute for the Biology of Stem Cells, University of California, Santa Cruz, Santa Cruz, CA 95064, USA.
Paloma MedinaInstitute for the Biology of Stem Cells, University of California, Santa Cruz, Santa Cruz, CA 95064, USA; Biomolecular Engineering, University of California, Santa Cruz, Santa Cruz, CA 95064, USA.
Anna E BeaudinInstitute for the Biology of Stem Cells, University of California, Santa Cruz, Santa Cruz, CA 95064, USA.
Scott W BoyerInstitute for the Biology of Stem Cells, University of California, Santa Cruz, Santa Cruz, CA 95064, USA; Program in Biomedical Science and Engineering, University of California, Santa Cruz, Santa Cruz, CA 95064, USA.
Michael HolinstatDepartment of Pharmacology, University of Michigan, Ann Arbor, MI 48109, USA.
Vanessa D JonssonInstitute for the Biology of Stem Cells, University of California, Santa Cruz, Santa Cruz, CA 95064, USA; Biomolecular Engineering, University of California, Santa Cruz, Santa Cruz, CA 95064, USA; Applied Mathematics, Genomics Institute, University of California, Santa Cruz, Santa Cruz, CA 95064, USA.
E Camilla ForsbergInstitute for the Biology of Stem Cells, University of California, Santa Cruz, Santa Cruz, CA 95064, USA; Biomolecular Engineering, University of California, Santa Cruz, Santa Cruz, CA 95064, USA. Electronic address: cforsber@ucsc.edu.

Funding

UNIVERSITY OF CALIFORNIA, SANTA CRUZ IMSD PROGRAMR25GM058903 · NIGMS · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI JURICA, MELISSA S · 1999 to 2019
$12.2M
Defining the cause and consequence of aging-specific platelet specification from hematopoietic stem cellsR01AG062879 · NIA · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI CAMILLA FORSBERG · 2019 to 2026
$4.9M
IRACDA at UCSC and CSUMBK12GM139185 · NIGMS · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI FORSBERG, CAMILLA, HINCK, LINDSAY E · 2020 to 2024
$4.1M
Role and Regulation of a Novel, Developmentally Restricted Hematopoietic Stem CellR01DK100917 · NIDDK · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI FORSBERG, CAMILLA · 2013 to 2024
$3.9M
Training Program/Molecular/Cell/Developmental BiologyT32GM008646 · NIGMS · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI STROME, SUSAN · 1999 to 2018
$3.7M
Training Program in Molecular, Cell, and Developmental BiologyT32GM133391 · NIGMS · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI Needhi Bhalla · 2019 to 2026
$3.0M
CytoFLEX LX Cell AnalyzerS10OD030423 · OD · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI FORSBERG, CAMILLA · 2021 to 2021
$297k
Hematopoietic circRNA-mediated intercellular communicationK00DK131504 · NIDDK · STANFORD UNIVERSITY · PI Roman E Reggiardo · 2024 to 2026
$269k
Defining regulators of hematopoietic stem cell self-renewal and lineage potentialF31HL151199 · NHLBI · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI WORTHINGTON, ATESH K · 2020 to 2022
$115k
Cell free RNA liquid biopsiesF99DK131504 · NIDDK · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI REGGIARDO, ROMAN E · 2021 to 2022
$88k
NHLBI NIH HHS F31 HL151199NIA NIH HHS R01 AG062879NIDDK NIH HHS F99 DK131504NIDDK NIH HHS K00 DK131504NIDDK NIH HHS R01 DK100917NIGMS NIH HHS K12 GM139185NIGMS NIH HHS R25 GM058903NIGMS NIH HHS T32 GM008646NIGMS NIH HHS T32 GM133391NIH HHS S10 OD030423
6 · The paper itself

Abstract

Platelet dysregulation is drastically increased with advanced age and contributes to making cardiovascular disorders the leading cause of death of elderly humans. Here, we reveal a direct differentiation pathway from hematopoietic stem cells into platelets that is progressively propagated upon aging. Remarkably, the aging-enriched platelet path is decoupled from all other hematopoietic lineages, including erythropoiesis, and operates as an additional layer in parallel with canonical platelet production. This results in two molecularly and functionally distinct populations of megakaryocyte progenitors. The age-induced megakaryocyte progenitors have a profoundly enhanced capacity to engraft, expand, restore, and reconstitute platelets in situ and upon transplantation and produce an additional platelet population in old mice. The two pools of co-existing platelets cause age-related thrombocytosis and dramatically increased thrombosis in vivo. Strikingly, aging-enriched platelets are functionally hyper-reactive compared with the canonical platelet populations. These findings reveal stem cell-based aging as a mechanism for platelet dysregulation and age-induced thrombosis.

Indexed as

AgingBlood PlateletsCell DifferentiationHematopoietic Stem CellsThrombosisAnimalsHumansMaleMegakaryocyte Progenitor CellsMegakaryocytesMiceMice, Inbred C57BLagingcardiovascular disordergenetic lineage tracinghematopoietic stem cellsmegakaryocyte progenitor cellsplatelet differentiation pathwayplatelet dysregulationthrombocytosisthrombosistransplantation

Identifiers

PMID38749423
PMCPMC12047039

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.